Lentitek
PrivateLast Round
Seed
Mar 5, 2025
Total Funding Raised
$1.69M
Company Overview
Lentitek operates in Healthcare & Life Sciences and is based in Edinburgh. Its latest recorded funding round was a Seed round in March 2025.
Lentitek is a biotechnology company that develops manufacturing technologies to enhance the quality, yield, and compatibility of lentiviral vectors used in advanced therapies such as cell and gene therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lentitek Comparables
Compare Lentitek with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vector BioMed, Inc. | 86% | |
| ViroCell Biologics | 81% | |
| Virica Biotech | 77% |
For institutional investors. Book with your work email.
Lentitek Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 5, 2025 | ||||
| Grant | Aug 28, 2024 | ||||
| Seed | May 30, 2023 | ||||
| Grant | Jun 13, 2022 |
For institutional investors. Book with your work email.
Lentitek Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| Gabriel Investments Ltd | Seed |
| Equity Gap | Seed |
| Scottish EDGE | Grant |
| Apollo Informal Investment | Seed |
| Industrial Biotechnology Innovation Centre | Grant |
| Gabriel Investments | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 24, 2026
Integrated technologies with ViroCell Biologics Ltd. for lentiviral vector manufacturing.
- Mar 24, 2026
PR Fire Limited selected for intelligent vector development.
For institutional investors. Book with your work email.
Lentitek Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Lentitek's valuation, stock price, and market status.
Is Lentitek a public or private company?
Lentitek is a private company.
What is the current stock price of Lentitek?
Lentitek is a private company, so its shares have no public market price. Caplight tracks Lentitek's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Lentitek worth (valuation)?
Valuation information for Lentitek is not publicly available.
Can I buy Lentitek stock?
Lentitek shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Lentitek's last funding round?
Lentitek's most recent funding round was Seed on March 5, 2025.
Who are the main investors in Lentitek?
Key investors in Lentitek include Gabriel Investments Ltd, Equity Gap, Gabriel Investments.
Will Lentitek IPO soon?
No public IPO plans have been announced for Lentitek.
How can I track Lentitek secondary market activity?
Caplight tracks bids, offers, and trades in Lentitek's shares on secondary markets.